39
The
th Annual Meeting of March 10-11, 2018 The Endocrine Society and The Diabetes Association of the R.O.C. (Taiwan)
DAROC-1
RECOMMENDATIONS FOR DIABETES MELLITUS FROM TAIWAN LIPID GUIDELINES HAO-CHANG HUNG Division of Endocrinology and Metabolism, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan,, Taiwan, ROC
Diabetes mellitus refers to a group of metabolic disorders characterized by the presence of hyperglycemia that results from insulin deficiency, insulin resistance, or both. Chronic hyperglycemia is associated with both microvascular and macrovascular complications. Intensive glycemic control reduces the risk of microvascular complications, but its effect on reducing macrovascular complications is less clear. Diabetic patients are frequently associated with dyslipidemia and atherosclerotic cardiovascular diseases. Diabetic dyslipidemia is featured with increased serum triglyceride, increased VLDL, decreased HDL-C, and increased small dense LDL-C. The risk of cardiovascular disease appears early in the course of dysglycemia and correlates with plasma glucose level. Aggressive management for lipid disorder and other risk factors has been proven to reduce macrovascular complications in these patients. Comprehensive assessment and treatment of dyslipidemia in diabetic patients are recommended, and it may be prudent to apply the same principles to prediabetic patients as well. Intensive lifestyle intervention is simple and cost-effective and should always be incorporated into dyslipidemia treatment plans.
58
